Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

- PMLiVE

NICE wants to stop saying ‘no’ – but needs pharma’s co-operation

Suggests Orkambi row has undermined confidence in NICE process

Three questions that should anchor your brand strategy

Ensuring the organisation is focused on pursuing the most attractive commercial opportunities

- PMLiVE

Allergy Tx hit hard as birch pollen product stumbles

Shares in the company went into a steep decline this morning

- PMLiVE

Blood disorder specialists Imara raises $63m

Arix Biosciences claims a 10% stake in the biotech

- PMLiVE

Bringing life to precision medicine

Harnessing the power of patient-derived organoids

- PMLiVE

Keytruda adds another NSCLC approval in Europe

Squamous NSCLC completes first-line dominance

Measures for measures

Why pharma’s marketing metrics must close the loop

Lucid Group Communications Limited

- PMLiVE

Gottlieb admonishes industry for clinical trial failings

Calls for faster uptake of novel trial design and methods

- PMLiVE

CHMP recommends new Keytruda dosing schedule

Will apply to eight indications across five tumour types

- PMLiVE

Liver specialist Genfit files $120m IPO on Nasdaq

Funds will go towards NASH candidate, a companion diagnostic and a liver disease drug

- PMLiVE

Francis exits Sandoz, reigniting spinoff rumours

Novartis says no such plans at present

- PMLiVE

Pharma Careers Q&A: Caroline Benson

Gemma Jones interviews Cuttsy+Cuttsy's Co-Founder and Director

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links